Management of Uremic Gastropathy

Primary Management Strategy: Dialysis Optimization

The American Journal of Kidney Diseases recommends optimizing dialysis adequacy to reduce uremic toxin burden, as gastrointestinal symptoms are direct manifestations of inadequate uremic toxin clearance 1, 2
For hemodialysis patients, the target Kt/V should be ≥1.4 per session (minimum 1.2) with sessions lasting at least 3 hours 3
For peritoneal dialysis patients, 24-hour clearances should be reassessed if failure to thrive occurs with no alternative explanation 1, 2

Frequent hemodialysis (short daily or nocturnal) may provide better uremic toxin control and symptom relief for patients with persistent symptoms despite adequate conventional dialysis 4
Home long hemodialysis (6-8 hours, 3-6 nights per week) can be considered for patients with lifestyle flexibility, but may increase vascular access complications and hypotension risks 4

Loss of residual kidney function from volume depletion, NSAID use, or overzealous blood pressure control should be systematically evaluated 1, 2
Decreased ultrafiltration from reduced dialysate dextrose concentration (PD patients) should be assessed 1, 2
Nonadherence to prescription should be checked by verifying supply orders, home inventory, and cycler memory systems 1, 2

Protein intake should be monitored by calculating normalized protein nitrogen appearance (nPNA) or dietary protein intake (DPI) during clearance assessments 1, 2
Target DPI should aim to maintain adequate nutrition despite symptoms, as uremic patients spontaneously decrease protein intake as GFR falls below 50 mL/min 1, 2
Dialysate losses should be accounted for, as PD patients lose 5-15 g protein and 2-4 g amino acids daily 1, 2

Avoiding nephrotoxic medications, such as NSAIDs, can help prevent loss of residual kidney function and worsen uremia 1, 2

Uremic gastropathy symptoms may indicate the need for dialysis initiation when accompanied by uremic signs, refractory symptoms, or protein-energy wasting 4
Kidney transplantation offers superior outcomes compared to dialysis for mortality and quality of life, and should be discussed with all appropriate candidates experiencing uremic complications 3

Peritonitis should not be overlooked in PD patients with GI symptoms, as protein losses double during even mild peritonitis episodes 1, 2